Cargando…

Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response

INTRODUCTION: Routine efficacy assessments of new tuberculosis (TB) treatments include quantitative solid culture or routine liquid culture, which likely miss quantification of drug tolerant bacteria. To improve these assessments, comparative analyses using additional measures such as quantification...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Julian S., McIvor, Amanda, Papadopoulos, Andrea O., Masangana, Tshepiso, Gordhan, Bhavna G., Waja, Ziyaad, Otwombe, Kennedy, Letutu, Matebogo, Kamariza, Mireille, Sterling, Timothy R., Bertozzi, Carolyn R., Martinson, Neil A., Kana, Bavesh D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877613/
https://www.ncbi.nlm.nih.gov/pubmed/36710965
http://dx.doi.org/10.3389/fcimb.2022.1064148
_version_ 1784878395467759616
author Peters, Julian S.
McIvor, Amanda
Papadopoulos, Andrea O.
Masangana, Tshepiso
Gordhan, Bhavna G.
Waja, Ziyaad
Otwombe, Kennedy
Letutu, Matebogo
Kamariza, Mireille
Sterling, Timothy R.
Bertozzi, Carolyn R.
Martinson, Neil A.
Kana, Bavesh D.
author_facet Peters, Julian S.
McIvor, Amanda
Papadopoulos, Andrea O.
Masangana, Tshepiso
Gordhan, Bhavna G.
Waja, Ziyaad
Otwombe, Kennedy
Letutu, Matebogo
Kamariza, Mireille
Sterling, Timothy R.
Bertozzi, Carolyn R.
Martinson, Neil A.
Kana, Bavesh D.
author_sort Peters, Julian S.
collection PubMed
description INTRODUCTION: Routine efficacy assessments of new tuberculosis (TB) treatments include quantitative solid culture or routine liquid culture, which likely miss quantification of drug tolerant bacteria. To improve these assessments, comparative analyses using additional measures such as quantification of differentially culturable tubercle bacteria (DCTB) are required. Essential for enabling this is a comparative measure of TB treatment responses using routine solid and liquid culture with liquid limiting dilutions (LLDs) that detect DCTB in sputum. METHODS: We recruited treatment-naïve TB patients, with and without HIV-infection, and serially quantified their sputum for DCTB over the course of treatment. RESULTS: Serial sputum sampling in 73 individuals during their first 14 days of treatment demonstrated that clearance of DCTB was slower compared to routine solid culture. Treatment response appeared to be characterized by four patterns: (1) Classic bi-phasic bacterial clearance; (2) early non-responders with slower clearance; (3) paradoxical worsening with an increase in bacterial count upon treatment initiation; and (4) non-responders with no change in bacterial load. During treatment, LLDs displayed greater bacterial yield when compared with quantitative solid culture. Upon treatment completion, 74% [46/62] of specimens displayed residual DCTB and within this group, two recurrences were diagnosed. Residual DCTB upon treatment completion was associated with a higher proportion of MGIT culture, GeneXpert, and smear positivity at two months post treatment. No recurrences occurred in the group without residual DCTB. DISCUSSION: These data indicate that DCTB assays detect distinct subpopulations of organisms in sputum that are missed by routine solid and liquid culture, and offer important alternatives for efficacy assessments of new TB treatments. The residual DCTB observed upon treatment completion suggests that TB treatment does not always eliminate all bacterial populations, a finding that should be investigated in larger cohorts.
format Online
Article
Text
id pubmed-9877613
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98776132023-01-27 Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response Peters, Julian S. McIvor, Amanda Papadopoulos, Andrea O. Masangana, Tshepiso Gordhan, Bhavna G. Waja, Ziyaad Otwombe, Kennedy Letutu, Matebogo Kamariza, Mireille Sterling, Timothy R. Bertozzi, Carolyn R. Martinson, Neil A. Kana, Bavesh D. Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Routine efficacy assessments of new tuberculosis (TB) treatments include quantitative solid culture or routine liquid culture, which likely miss quantification of drug tolerant bacteria. To improve these assessments, comparative analyses using additional measures such as quantification of differentially culturable tubercle bacteria (DCTB) are required. Essential for enabling this is a comparative measure of TB treatment responses using routine solid and liquid culture with liquid limiting dilutions (LLDs) that detect DCTB in sputum. METHODS: We recruited treatment-naïve TB patients, with and without HIV-infection, and serially quantified their sputum for DCTB over the course of treatment. RESULTS: Serial sputum sampling in 73 individuals during their first 14 days of treatment demonstrated that clearance of DCTB was slower compared to routine solid culture. Treatment response appeared to be characterized by four patterns: (1) Classic bi-phasic bacterial clearance; (2) early non-responders with slower clearance; (3) paradoxical worsening with an increase in bacterial count upon treatment initiation; and (4) non-responders with no change in bacterial load. During treatment, LLDs displayed greater bacterial yield when compared with quantitative solid culture. Upon treatment completion, 74% [46/62] of specimens displayed residual DCTB and within this group, two recurrences were diagnosed. Residual DCTB upon treatment completion was associated with a higher proportion of MGIT culture, GeneXpert, and smear positivity at two months post treatment. No recurrences occurred in the group without residual DCTB. DISCUSSION: These data indicate that DCTB assays detect distinct subpopulations of organisms in sputum that are missed by routine solid and liquid culture, and offer important alternatives for efficacy assessments of new TB treatments. The residual DCTB observed upon treatment completion suggests that TB treatment does not always eliminate all bacterial populations, a finding that should be investigated in larger cohorts. Frontiers Media S.A. 2023-01-12 /pmc/articles/PMC9877613/ /pubmed/36710965 http://dx.doi.org/10.3389/fcimb.2022.1064148 Text en Copyright © 2023 Peters, McIvor, Papadopoulos, Masangana, Gordhan, Waja, Otwombe, Letutu, Kamariza, Sterling, Bertozzi, Martinson and Kana https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Peters, Julian S.
McIvor, Amanda
Papadopoulos, Andrea O.
Masangana, Tshepiso
Gordhan, Bhavna G.
Waja, Ziyaad
Otwombe, Kennedy
Letutu, Matebogo
Kamariza, Mireille
Sterling, Timothy R.
Bertozzi, Carolyn R.
Martinson, Neil A.
Kana, Bavesh D.
Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title_full Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title_fullStr Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title_full_unstemmed Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title_short Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
title_sort differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877613/
https://www.ncbi.nlm.nih.gov/pubmed/36710965
http://dx.doi.org/10.3389/fcimb.2022.1064148
work_keys_str_mv AT petersjulians differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT mcivoramanda differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT papadopoulosandreao differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT masanganatshepiso differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT gordhanbhavnag differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT wajaziyaad differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT otwombekennedy differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT letutumatebogo differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT kamarizamireille differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT sterlingtimothyr differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT bertozzicarolynr differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT martinsonneila differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse
AT kanabaveshd differentiallyculturabletuberclebacteriaasameasureoftuberculosistreatmentresponse